August 2025 – Ketamine was recently removed from the FDA Drug Shortage List. In alignment with our commitment to the highest standards of regulatory compliance, Leiters Health, an FDA-Registered 503B provider, has transitioned our production of Ketamine syringes to source exclusively from finished dose product (FDP), rather than active pharmaceutical ingredient (API).
